Bio-IT World February 5, 2025
10X Genomics launched a spate of new products in 2024 in both their single cell and spatial areas. Xenium 5K and Visium HD both offered new capabilities for spatial transcriptomics. New Chromium products were intended to democratize access to single cell analysis. “Our view is that eventually, every relevant sample will need to be analyzed with single cell and spatial context,” said Serge Saxonov, 10X CEO and co-founder, in his 2025 J.P. Morgan Healthcare Conference presentation.
10X has historically believed that its products would replace much of the conventional life sciences toolkit, not as one-to-one replacements, but by, “transforming, changing, the way that research is done,” Saxonov said. The 10X technologies span applications and therapeutic areas....
Today's Sponsors
Today's Sponsor